Pay in 4 interest-free payments of $2.50 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
cutting logistics CO2 by an estimated 18% and reducing lead costs ~12% versus centralized production
5 billion in agricultural commodities traded
and managing extensive information
Licensing ensures compliance with regulatory standards
AXSOME THERAPEUTICS BUSINESS MODEL CANVAS TEMPLATE RESEARCH B_43 cutting logistics CO2 by anAxsome Therapeutics BMC: Strategic Blueprint for CNS Value, Partners, and Revenue Unlock the full strategic blueprint behind Axsome Therapeutics's business model: this concise Business Model Canvas maps value propositions, target patient and payer segments, key partnerships, and revenue levers that drive growth in CNS therapeutics. Partnerships Strategic Licensing with Pfizer for Sunosi Rights Axsome Therapeutics acquired global rights to Sunosi from
US$ 115.00
US$ 1674.50
US$ 274.50
US$ 48.95
US$ 15.95
